Ward, Michael M <br/><br/>
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication?  [electronic resource] 

 -  Arthritis and rheumatism  Jun 2011 
 - 1472-4 p.  digital 
<br/><br/> Publication Type: Comment; Editorial; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1529-0131 
<br/><br/><label>Standard No.: </label>10.1002/art.30225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--therapeutic use<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Spondylitis, Ankylosing--drug therapy<br/>Sulfasalazine--therapeutic use